Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Gisselbrecht C, Lepage E, Molina T, Quesnel B, Fillet G, Lederlin P, Coiffier B, Tilly H, Gabarre J, Guilmin F, Hermine O, Reyes F; Groupe d'Etude des Lymphomes de l'Adulte.
Gisselbrecht C, et al.
J Clin Oncol. 2002 May 15;20(10):2472-9. doi: 10.1200/JCO.2002.02.125.
J Clin Oncol. 2002.
PMID: 12011124
Free article.
Clinical Trial.